FY2025 · ended Dec 31, 2025 · Revenue $441.33M, +13.6% YoY · Filed Feb 18, 2026
Artivion, Inc. (AORT) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $441.3 million and net income of $9.8 million. Free cash flow was $839,000. As of Jun 30, 2026 it held $77.3 million in cash and investments and $408.0 million in total debt.
Revenue (TTM)
$471.47M
+16.4% vs year-ago TTM
Net income (TTM)
$-3.17M
+82.3% vs year-ago TTM
Operating cash flow (TTM)
$41.71M
+112.2% vs year-ago TTM
Free cash flow (TTM)
$-9.16M
-219.5% vs year-ago TTM
EPS (TTM)
$-0.06
+84.6% vs year-ago TTM
Dividend per share
$0.00
Shares outstanding
47.88M
+13.9% vs prior year
Net cash
$-330.65M
as of Jun 30, 2026
Operating margin
4.4%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- AORT (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Kennesaw, GA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 784199
- Former names
- CRYOLIFE INC (until Jan 6, 2022)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $441.3M | $388.5M | $354.0M | $313.8M | $298.8M |
| Operating income | $33.7M | $38.9M | $5.7M | $6.2M | $8.1M |
| Net income | $9.8M | -$13.4M | -$30.7M | -$19.2M | -$14.8M |
| Diluted EPS | $0.21 | -$0.32 | -$0.75 | -$0.48 | -$0.38 |
| Operating cash flow | $39.9M | $22.2M | $18.8M | -$5.2M | -$2.6M |
| Free cash flow | $839,000 | $11.0M | $9.1M | -$15.9M | -$15.7M |
| Total assets | $884.8M | $789.1M | $792.4M | $762.8M | $793.1M |
| Total liabilities | $436.6M | $512.9M | $510.6M | $478.5M | $492.3M |
| Stockholders' equity | $448.2M | $276.2M | $281.8M | $284.3M | $300.7M |
| Cash and investments | $64.9M | $53.5M | $58.9M | $39.4M | $55.0M |
| Total debt | $257.6M | $362.3M | $358.3M | $356.8M | $362.0M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 18, 2026 | May 18, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 15, 2026 | May 12, 2026 |
| 10-Q | Quarterly report | May 8, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Material agreement, Results of operations
|
May 7, 2026 | May 7, 2026 |
All 1000 Artivion, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.